Wen Xi X - OmicsDI

Show results for

Unknown (165)
Transcriptomics (20)
Genomics (5)
Metabolomics (3)
Proteomics (1)

Organisms

Homo sapiens (19)
Mus musculus (4)
Rattus norvegicus (2)

Repository

biostudies-arrayexpress (24)
MetaboLights (3)
EGA (1)
MassIVE (1)

Disease

Small cell lung carcinoma (1)

Technology Type

Mass spectrometry (2)
Mass spectrometry assay (1)

Instrument Platform

Liquid Chromatography MS - positive - hilic (2)
Illumina HiSeq 2500 (1)
Orbitrap Fusion Lumos (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2014 (6)
2016 (4)
2012 (4)
2010 (4)
2023 (2)
2025 (2)
2020 (1)
2013 (1)
2011 (1)
2009 (1)
2005 (1)
2004 (1)

CHEBI ID

CHEBI:116314 (1)
CHEBI:125610 (1)
CHEBI:125678 (1)
CHEBI:12936 (1)
CHEBI:131744 (1)
CHEBI:131887 (1)
CHEBI:132223 (1)
CHEBI:133521 (1)
CHEBI:134021 (1)
CHEBI:137245 (1)
CHEBI:137271 (1)
CHEBI:141146 (1)
CHEBI:142245 (1)
CHEBI:146131 (1)
CHEBI:146206 (1)
CHEBI:15318 (1)
CHEBI:15333 (1)
CHEBI:15584 (1)
CHEBI:15616 (1)
CHEBI:15765 (1)
CHEBI:157859 (1)
CHEBI:15891 (1)
CHEBI:15956 (1)
CHEBI:16040 (1)
CHEBI:16119 (1)
CHEBI:162277 (1)
CHEBI:162295 (1)
CHEBI:162377 (1)
CHEBI:162381 (1)
CHEBI:162584 (1)

Metabolite Name

Glutathione, oxidized (2)
Indole (2)
(+)-6-aminopenicillanic acid (1)
(+-)12-HETE (1)
(-)-catechin gallate (1)
(1-(5-fluoropentyl)-1h-indazole-3-carbonyl)-l-valine (1)
(1-acetyloxy-3-hydroxy-6,8a-dimethyl-7-oxo-3-propan-2-yl-2,3a,4,8-tetrahydro-1h-azulen-4-yl) 4-hydroxybenzoate (1)
(19r)-9-acetyl-19-hydroxy-10,14-dimethyl-20-oxopentacyclo[11.8.0.0<2,10>.0<4,9 >.0<14,19>]henicos-17-yl acetate (1)
(1e,4e)-1,5-bis(4-methoxyphenyl)penta-1,4-dien-3-one (1)
(2-aminoethoxy)[2-[docosa-4.7.10.13.16.19-hexaenoyloxy]-3-[hexadec-1-en-1-yloxy]propoxy]phosphinic acid (1)
(2-aminoethoxy)[2-[docosa-4.7.10.13.16.19-hexaenoyloxy]-3-[octadeca-1.9-dien-1-yloxy]propoxy]phosphinic acid (1)
(2-aminoethoxy)[3-[hexadec-1-en-1-yloxy]-2-(hexadecanoyloxy)propoxy]phosphinic acid (1)
(2-aminoethoxy)[3-[hexadec-1-en-1-yloxy]-2-[icosa-5.8.11.14-tetraenoyloxy]propoxy]phosphinic acid (1)
(2S,2'S)-Pyrosaccharopine (1)
(2e,6e,10e)-13-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydrochromen-2-yl]-2,6,10-trimethyltrideca-2,6,10-trienoic acid (1)
(2s,3r,5r,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2r,3r,5r)-2,3,6-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-6-one (1)
(3S,5S)-3,5-Diaminohexanoate (1)
(3s,4r)-7-hydroxy-3-[(3s,4r)-7-hydroxy-4-(4-hydroxyphenyl)-2-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydrochromen-3-yl]-4-(4-hydroxyphenyl)-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydrochromen-2-one (1)
(4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid (1)
(4aS,5aS,12aS)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboximidic acid (1)
(4e,8e)-10-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1h-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoic acid (1)
(5e)-3,4,9-trihydroxy-2-propyl-2,3,4,7,8,9-hexahydrooxecin-10-one (1)
(9e)-11a-hydroxy-3,6,10-trimethyl-6,7,8,11-tetrahydro-4h-cyclodeca[b]furan-2,5-dione (1)
(R)-3,4-Dihydro-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2H-1-benzopyran-6-ol (1)
(S)-2-Hydroxyglutarate (1)
(Z,Z)-3,6-Dodecadien-1-ol (1)
(n-(-2-acetamido))-2-aminoethanesulfonic acid (1)
(r)-butaprost (free acid) (1)
.alpha.-d-galactose 1-phosphate (1)
.beta.-hydroxypropionic acid (1)

Study type

Transcription profiling by array (12)
RNA-seq of coding RNA (4)
ChIP-seq (3)
ChIP-chip by tiling array (1)
ChIP-chip by array (1)
Comparative genomic hybridization by array (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of non coding RNA (1)

Release Date

2022 (24)
2025 (18)
2023 (18)
2016 (14)
2021 (14)
2014 (13)
2019 (13)
2020 (12)
2018 (12)
2017 (12)
2024 (10)
2012 (6)
2015 (5)
2010 (4)
2026 (4)
2013 (3)
2011 (2)
2009 (1)
2005 (1)
2004 (1)
2008 (1)
2006 (1)

Previous page
1 / 20
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 20
Next page

Sort by:

Relevance

Page size

The number of metabolic syndrome risk factors predicts alterations in gut microbiota in Chinese children from the Huantai study.

Not available

S-EPMC10120097 | biostudies-literature

Global prevalence of WHO infant feeding practices in 57 LMICs in 2010-2018 and time trends since 2000 for 44 LMICs.

Not available

S-EPMC8343261 | biostudies-literature

AF9 Links Histone Acetylation to DOT1L-Mediated H3K79 Methylation

The recognition of modified histones by “reader” proteins constitutes a key mechanism regulating gene expression in the chromatin context. Compared with the great variety of readers for histone methylation, few protein modules that recognize histone acetylation are known. Here we show that the evolu...

ORGANISM(S): Homo sapiens

2014-12-11 | E-GEOD-60366 | biostudies-arrayexpress

SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer.

Not available

S-EPMC5944004 | biostudies-literature

Histone variant H3.3-specific readout of H3K36 trimethylation by ZMYND11 links transcription elongation control to tumour suppression

Recognition of modified histones by “reader” proteins plays a critical role in the regulation of transcription1. H3K36 trimethylation (H3K36me3) is deposited onto the nucleosomes in the transcribed regions following RNA polymerase II (Pol II) elongation. In yeast, this mark in turn recruits epigenet...

ORGANISM(S): Homo sapiens

2014-02-24 | E-GEOD-48423 | biostudies-arrayexpress

Landscape of X chromosome inactivation across human tissues.

Not available

S-EPMC5685192 | biostudies-literature

RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro.

Not available

S-EPMC3584577 | biostudies-literature

Activities of daily living limitations and family doctor contract services among overweight and obese older adults: is there a rural-urban difference?

Not available

S-EPMC10612158 | biostudies-literature

KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer.